911 — Qianhai Health Holdings Income Statement
0.000.00%
Last trade - 00:00
- HK$50.83m
- HK$31.80m
- HK$961.29m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 588 | 761 | 283 | 1,962 | 961 |
Cost of Revenue | |||||
Gross Profit | 32.7 | 41.6 | 4.62 | -162 | -35.6 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 558 | 758 | 284 | 2,195 | 1,014 |
Operating Profit | 29.5 | 2.61 | -0.38 | -234 | -52.7 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 26.7 | -0.804 | -0.888 | -234 | -52.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 26.7 | -0.804 | -0.888 | -234 | -52.7 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 26.7 | -0.804 | -0.888 | -234 | -52.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 26.7 | -0.804 | -0.888 | -234 | -52.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.166 | -0.008 | -0.09 | -1.51 | -0.311 |